Concanavalin-A triggers inflammatory response through JAK/STAT3 signalling and modulates MT1-MMP regulation of COX-2 in mesenchymal stromal cells

Experimental Cell Research

Volumn 318, Issue 19, 2012, Pages 2498-2506

  Akla, Naoufal ^a   Pratt, Jonathan ^a   Annabi, Borhane ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

COX 2; Inflammation; Mesenchymal stromal cells; MT1 MMP; STAT3

Indexed keywords

CONCANAVALIN A; CYCLOOXYGENASE 2; INTERSTITIAL COLLAGENASE; JANUS KINASE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; STAT3 PROTEIN;

ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; GENE SILENCING; IMMUNOBLOTTING; INFLAMMATION; INHIBITION KINETICS; MESENCHYMAL STROMA CELL; MICROENVIRONMENT; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

EID: 84866315964     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.08.003     Document Type: Article

References (62)

1. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
2. Horwitz E.M., Le Blanc K., Dominici M., Mueller I., Slaper-Cortenbach I., Marini F.C., Deans R.J., Krause D.S., Keating A. International society for cellular therapy. clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 2005, 7:393-395.
3. Wong R.S. Mesenchymal stem cells: angels or demons?. J. Biomed. Biotechnol. 2011, 2011:459510.
4. Studeny M., Marini F.C., Champlin R.E., Zompetta C., Fidler I.J., Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res. 2002, 62:3603-3608.
5. Nakamizo A., Marini F., Amano T., Khan A., Studeny M., Gumin J., Chen J., Hentschel S., Vecil G., Dembinski J., Andreeff M., Lang F.F. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005, 65:3307-3318.
6. Annabi B., Naud E., Lee Y.T., Eliopoulos N., Galipeau J. Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors. J. Cell. Biochem. 2004, 91:1146-1158.
7. Birnbaum T., Roider J., Schankin C.J., Padovan C.S., Schichor C., Goldbrunner R., Straube A. Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. J. Neuro-Oncol. 2007, 83:241-247.
8. Sethi G., Shanmugam M.K., Ramachandran L., Kumar A.P., Tergaonkar V. Multifaceted link between cancer and inflammation. Biosci. Rep. 2012, 32:1-15.
9. Greene E.R., Huang S., Serhan C.N., Panigrahy D. Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediators 2011, 96:27-36.
10. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
11. Annabi B., Lee Y.T., Turcotte S., Naud E., Desrosiers R.R., Champagne M., Eliopoulos N., Galipeau J., Béliveau R. Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells 2003, 21:337-347.
12. Annabi B., Thibeault S., Lee Y.T., Bousquet-Gagnon N., Eliopoulos N., Barrette S., Galipeau J., Béliveau R. Matrix metalloproteinase regulation of sphingosine-1-phosphate-induced angiogenic properties of bone marrow stromal cells. Exp Hematol. 2003, 31:640-649.
13. Karow M., Popp T., Egea V., Ries C., Jochum M., Neth P. Wnt signaling in mouse mesenchymal stem cells: impact on proliferation, invasion and MMP expression. J. Cell. Mol. Med. 2009, 13:2506-2520.
14. Gingras D., Michaud M., Di Tomasso G., Beliveau E., Nyalendo C., Beliveau R. Sphingosine-1-phosphate induces the association of membrane-type 1 matrix metalloproteinase with p130Cas in endothelial cells. FEBS Lett. 2008, 582:399-404.
15. Uekita T., Gotoh I., Kinoshita T., Itoh Y., Sato H., Shiomi T., Okada Y., Seiki M. Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein-1 is a new member of the Cupin superfamily. A possible multifunctional protein acting as an invasion suppressor down-regulated in tumors. J. Biol. Chem. 2004, 279:12734-12743.
16. Proulx-Bonneau S., Guezguez A., Annabi B. A concerted HIF-1α/MT1-MMP signaling axis regulates the expression of the 3BP2 adaptor protein in hypoxic mesenchymal stromal cells. PLoS One 2011, 6:e21511.
17. Nyalendo C., Michaud M., Beaulieu E., Roghi C., Murphy G., Gingras D., Beliveau R. Src-dependent phosphorylation of membrane type I matrix metalloproteinase on cytoplasmic tyrosine 573: role in endothelial and tumor cell migration. J. Biol. Chem. 2007, 282:15690-15699.
18. Fortier S., Labelle D., Sina A., Moreau R., Annabi B Silencing of the MT1-MMP/ G6PT axis suppresses calcium mobilization by sphingosine-1-phosphate in glioblastoma cells. FEBS Lett. 2008, 582:799-804.
19. Belkaid A., Fortier S., Cao J., Annabi B. Necrosis induction in glioblastoma cells reveals a new bioswitch function for the MT1-MMP/G6PT signaling axis in proMMP-2 activation versus cell death decision. Neoplasia 2007, 9:332-430.
20. Fortier S., Touaibia M., Lord-Dufour S., Galipeau J., Roy R., Annabi B. Tetra- and hexavalent mannosides inhibit the pro-apoptotic, antiproliferative and cell surface clustering effects of concanavalin-A: impact on MT1-MMP functions in marrow-derived mesenchymal stromal cells. Glycobiology 2008, 18:195-204.
21. Annabi B., Laflamme C., Sina C.A., Lachambre M.P., Béliveau R. A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells. J. Neuroinflammation 2009, 6:8.
22. Sina A., Proulx-Bonneau S., Roy A., Poliquin L., Cao J., Annabi B. The lectin concanavalin-A signals MT1-MMP catalytic independent induction of COX-2 through an IKKgamma/NF-kappaB-dependent pathway. J. Cell. Commun. Signal. 2010, 4:31-38.
23. Nakada M., Kita D., Futami K., Yamashita J., Fujimoto N., Sato H., Okada Y. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. J. Neurosurg. 2001, 94:464-473.
24. Ivanenkov Y.A., Balakin K.V., Lavrovsky Y. Small molecule inhibitors of NF-kB and JAK/STAT signal transduction pathways as promising anti-inflammatory therapeutics. Mini. Rev. Med. Chem. 2011, 11:55-78.
25. Lord-Dufour S., Copland I.B., Levros L.C., Post M., Das A., Khosla C., Galipeau J., Rassart E., Annabi B. Evidence for transcriptional regulation of the glucose-6-phosphate transporter by HIF-1alpha: targeting G6PT with mumbaistatin analogs in hypoxic mesenchymal stromal cells. Stem Cells 2009, 27:489-497.
26. Lendeckel U., Wex T., Kähne T., Frank K., Reinhold D., Ansorge S. Expression of the aminopeptidase N (CD13) gene in the human T cell lines HuT78 and H9. Cell. Immunol. 1994, 153:214-226.
27. Bauvois B., Dauzonne D. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects. Med. Res. Rev. 2006, 26:88-130.
28. Sina A., Lord-Dufour S., Annabi B. B, Cell-based evidence for aminopeptidase N/CD13 inhibitor actinonin targeting of MT1-MMP-mediated proMMP-2 activation. Cancer Lett. 2009, 279:171-176.
29. Pratt J., Roy R., Annabi B. Concanavalin-A-induced autophagy biomarkers requires membrane type-1 matrix metalloproteinase intracellular signaling in glioblastoma cells. Glycobiology 2012, 22:1245-1255.
30. Atkinson G.P., Nozell S.E., Benveniste E.T. NF-kappaB and STAT3 signaling in glioma: targets for future therapies. Expert Rev. Neurother. 2010, 10:575-586.
31. Van Meir E.G., Hadjipanayis C.J., Norden A.D., Shu H.K., Wen P.Y., Olson J.J. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J. Clin. 2010, 60:166-193.
32. Tso C.L., Shintaku P., Chen J., Liu Q., Liu J., Chen Z., Yoshimoto K., Mischel P.S., Cloughesy T.F., Liau L.M., Nelson S.F. Primary glioblastomas express mesenchymal stem-like properties. Mol. Cancer Res. 2006, 4:607-619.
33. Wang S., Qu X., Zhao R.C. Clinical applications of mesenchymal stem cells. J. Hematol. Oncol. 2012, 5:19.
34. Ben-Neriah Y., Karin M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 2011, 12:715-723.
35. Yu S.C., Ping Y.F., Yi L., Zhou Z.H., Chen J.H., Yao X.H., Gao L., Wang J.M., Bian X.W. Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett. 2008, 265:124-134.
36. Sen, Targeting E. inflammation-induced transcription factor activation: an open frontier for glioma therapy. Drug Discov. Today 2011, 16:1044-1051.
37. Jin R., Yang G., Li G. Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol. Dis. 2010, 38:376-385.
38. Prakobwong S., Khoontawad J., Yongvanit P., Pairojkul C., Hiraku Y., Sithithaworn P., Pinlaor P., Aggarwal B.B., Pinlaor S. Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis. Int. J. Cancer 2011, 129:88-100.
39. Syed D.N., Afaq F., Sarfaraz S., Khan N., Kedlaya R., Setaluri V., Mukhtar H. Delphinidin inhibits cell proliferation and invasion via modulation of Met receptor phosphorylation. Toxicol. Appl. Pharmacol. 2008, 231:52-60.
40. Masuda M., Suzui M., Lim J.T., Deguchi A., Soh J.W., Weinstein I.B. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J. Exp. Ther. Oncol. 2002, 2:350-359.
41. A. Vézina, R. Chokor, B. Annabi, EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells, Cancer Immunol Immunother.,, in press. http://dx.doi.org/10.1007/s00262-012-1301-x.
42. Bhardwaj A., Sethi G., Vadhan-Raj S., Bueso-Ramos C., Takada Y., Gaur U., Nair A.S., Shishodia S., Aggarwal B.B. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 2007, 109:2293-2302.
43. Yadav V.R., Prasad S., Sung B., Kannappan R., Aggarwal B.B. Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer. Toxins (Basel) 2010, 2:2428-2466.
44. Annabi B., Lachambre M.P., Bousquet-Gagnon N., Page M., Gingras D., Beliveau R. Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Biochim. Biophys. Acta 2002, 1542:209-220.
45. Annabi B., Bouzeghrane M., Moumdjian R., Moghrabi A., Béliveau R. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg. J. Neurochem. 2005, 94:906-916.
46. Annabi B., Lee Y.T., Martel C., Pilorget A., Bahary J.P., Béliveau R. Radiation induced-tubulogenesis in endothelial cells is antagonized by the antiangiogenic properties of green tea polyphenol (-) epigallocatechin-3-gallate. Cancer Biol. Ther. 2003, 2:642-649.
47. McLaughlin N., Annabi B., Lachambre M.P., Kim K.S., Bahary J.P., Moumdjian R., Béliveau R. Combined low dose ionizing radiation and green tea-derived epigallocatechin-3-gallate treatment induces human brain endothelial cells death. J. Neurooncol. 2006, 80:111-121.
48. B. Annabi, E. Vaillancourt-Jean, R. Béliveau, MT1-MMP expression level status dictates the in vitro action of lupeol on inflammatory biomarkers MMP-9 and COX-2 in medulloblastoma cells, Inflammopharmacology,, in press. http://dx.doi.org/10.1007/s10787-012-0142-8.
49. Siebenlist U. Barriers come down. Nature 2001, 412:601-603.
50. Waris G., Tardif K.D., Siddiqui A. Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT3. Biochem. Pharmacol. 2002, 64:1425-1430.
51. Proulx-Bonneau S., Pratt J., Annabi B. A role for MT1-MMP as a cell death sensor/effector through the regulation of endoplasmic reticulum stress in U87 glioblastoma cells. J. Neurooncol. 2011, 104:33-43.
52. Sminia P., Stoter T.R., van der Valk P., Elkhuizen P.H., Tadema T.M., Kuipers G.K., Vandertop W.P., Lafleur M.V., Slotman B.J. Expression of cyclooxygenase-2 and epidermal growth factor receptor in primary and recurrent glioblastoma multiforme. J. Cancer. Res. Clin. Oncol. 2005, 131:653-661.
53. New P. Cyclooxygenase in the treatment of glioma: its complex role in signal transduction. Cancer Control 2004, 11:152-164.
54. Kuipers G.K., Slotman B.J., Wedekind L.E., Stoter T.R., Berg J., Sminia P., Lafleur M.V. Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration. Int. J. Radiat. Biol. 2007, 83:677-685.
55. Schleicher S.M., Moretti L., Varki V., Lu B. Progress in the unraveling of the endoplasmic reticulum stress/autophagy pathway and cancer: implications for future therapeutic approaches. Drug Resist. Update 2010, 13:79-86.
56. Batten P., Rosenthal N.A., Yacoub M.H. Immune response to stem cells and strategies to induce tolerance. Philos. Trans. R. Soc. London B. Biol. Sci. 2007, 362:1343-1356.
57. Krampera M., Glennie S., Dyson J., Scott D., Laylor R., Simpson E., Dazzi F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003, 101:3722-3729.
58. Klyushnenkova E., Mosca J.D., Zernetkina V., Majumdar M.K., Beggs K.J., Simonetti D.W., Deans R.J., McIntosh K.R. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J. Biomed. Sci. 2005, 12:47-57.
59. Liu G., Atteridge C.L., Wang X., Lundgren A.D., Wu J.D. The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinases. J. Immunol. 2010, 184:3346-3350.
60. Kajita M., Itoh Y., Chiba T., Mori H., Okada A., Kinoh H., Seiki M. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol. 2001, 153:893-904.
61. Annabi B., Thibeault S., Moumdjian R., Béliveau R. Hyaluronan cell surface binding is induced by type I collagen and regulated by caveolae in glioma cells. J. Biol. Chem. 2004, 279:21888-21896.
62. Welte T., Zhang S.S., Wang T., Zhang Z., Hesslein D.G., Yin Z., Kano A., Iwamoto Y., Li E., Craft J.E., Bothwell A.L., Fikrig E., Koni P.A., Flavell R.A., Fu X.Y. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc. Natl. Acad. Sci. U S A 2003, 100:1879-1884.